投稿信息
員@2x.png)
稿件收錄要求
Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1172-7047.
CNS Drugs is your source for essential information about the treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology, to drugs in development and guidelines for clinical practice. CNS Drugs' structured program of peer reviewed articles written by international experts provides essential reading each month for pharmaceutical industry clinical researchers, clinical pharmacologists, drug information pharmacists and specialist clinicians in the CNS area.
CNS Drugs為研究人員和醫(yī)療保健專(zhuān)業(yè)人士提供了有關(guān)用于治療神經(jīng)和精神疾病的藥物療法的最重要方面的重要信息。
該期刊通過(guò)評(píng)論和原創(chuàng)研究文章的計(jì)劃，討論了與這些疾病的藥物治療有關(guān)的主要問(wèn)題，包括主要類(lèi)別藥物的藥理學(xué)、功效和副作用；新開(kāi)發(fā)藥物和藥物類(lèi)別的信息；對(duì)神經(jīng)和精神疾病病因的最新研究的治療意義；以及特定臨床情況的實(shí)際管理。
作為一本混合型期刊，《CNS Drugs》不向采用傳統(tǒng)訂閱式出版方式的作者收取出版費(fèi)用，但如果作者愿意或其資助者要求，則提供以開(kāi)放獲取方式出版已接受文章的選項(xiàng)
?
